Orit Cohen‐Barak

1.2k total citations
24 papers, 913 citations indexed

About

Orit Cohen‐Barak is a scholar working on Physiology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Orit Cohen‐Barak has authored 24 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 5 papers in Molecular Biology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Orit Cohen‐Barak's work include Migraine and Headache Studies (4 papers), melanin and skin pigmentation (3 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (3 papers). Orit Cohen‐Barak is often cited by papers focused on Migraine and Headache Studies (4 papers), melanin and skin pigmentation (3 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (3 papers). Orit Cohen‐Barak collaborates with scholars based in United States, Israel and Japan. Orit Cohen‐Barak's co-authors include Murray H. Brilliant, Nobuko Hagiwara, Richard A. King, J.M. Newton, Muriel T. Davisson, John M. Gardner, Drew T. Erickson, Ofer Spiegelstein, Deborah Fuchs and Murray H. Brilliant and has published in prestigious journals such as Nucleic Acids Research, The American Journal of Human Genetics and Molecular Biology of the Cell.

In The Last Decade

Orit Cohen‐Barak

23 papers receiving 884 citations

Peers

Countries citing papers authored by Orit Cohen‐Barak

Since Specialization

Citations

This map shows the geographic impact of Orit Cohen‐Barak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orit Cohen‐Barak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orit Cohen‐Barak more than expected).

Fields of papers citing papers by Orit Cohen‐Barak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orit Cohen‐Barak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orit Cohen‐Barak. The network helps show where Orit Cohen‐Barak may publish in the future.

Co-authorship network of co-authors of Orit Cohen‐Barak

This figure shows the co-authorship network connecting the top 25 collaborators of Orit Cohen‐Barak. A scholar is included among the top collaborators of Orit Cohen‐Barak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orit Cohen‐Barak. Orit Cohen‐Barak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Scaling Approaches for Pediatric Dose Selection: The Fremanezumab (AJOVY®) Journey to Select a Phase 3 Dose Using Pharmacokinetic Data from a Phase 1 Study 2021 ·Pharmaceutics ·(unknown), Orit Cohen‐Barak, (unknown), Jill Fiedler‐Kelly	2
2	Dose selection for fremanezumab (AJOVY) phase 3 pediatric migraine studies using pharmacokinetic data from a pediatric phase 1 study and a population pharmacokinetic modeling and simulation approach 2021 ·Cephalalgia ·Orit Cohen‐Barak, (unknown), (unknown), Jill Fiedler‐Kelly, (unknown), Michael J. Brennan, (unknown), Michèle Rasamoelisolo, Hussein Hallak, Pippa S. Loupe, (unknown), Xiaoping Ning, Micha Levi, Andrew H. Ahn, Laura Rabinovich‐Guilatt	7
3	Effect of Fremanezumab Monthly and Quarterly Doses on Efficacy Responses 2020 ·Headache The Journal of Head and Face Pain ·Jill Fiedler‐Kelly, Julie Passarell, Elizabeth Ludwig, Micha Levi, Orit Cohen‐Barak	7
4	Pharmacokinetics, metabolism and safety of deuterated L‐DOPA (SD‐1077)/carbidopa compared to L‐DOPA/carbidopa following single oral dose administration in healthy subjects 2018 ·British Journal of Clinical Pharmacology ·(unknown), (unknown), (unknown), Margaret Bradbury, Orit Cohen‐Barak, Igor D. Grachev, Serge Guzy, Pippa S. Loupe, Micha Levi, Mirna McDonald, Juha‐Matti Savola, Spyros Papapetropoulos, William Tracewell, Maria Velinova, Ofer Spiegelstein	31
5	Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence 2016 ·Drug and Alcohol Dependence ·Yossi Gilgun‐Sherki, Rom E. Eliaz, David J. McCann, Pippa S. Loupe, Eli Eyal, (unknown), Orit Cohen‐Barak, Hussein Hallak, Nora Chiang, (unknown)	32
6	The Pharmacokinetics and Pharmacodynamics of TV-1106, a Once Weekly GH Supplement: Results from a Phase 2 Study of TV-1106 in Adults with GH Deficiency 2015 ·Orit Cohen‐Barak, (unknown), Martin Bidlingmaier, (unknown), (unknown), (unknown), Kathleen Butler	0
7	Assessment of Pharmacokinetic and Pharmacodynamic Interactions Between Albumin-Fused Mutated Butyrylcholinesterase and Intravenously Administered Cocaine in Recreational Cocaine Users 2015 ·Journal of Clinical Psychopharmacology ·Megan J. Shram, Orit Cohen‐Barak, Bijan Chakraborty, Merav Bassan, Kerri A. Schoedel, Hussein Hallak, Eli Eyal, Sivan Weiss, (unknown), Edward M. Sellers, (unknown), Ofer Spiegelstein	42
8	Safety, pharmacokinetic and pharmacodynamic properties of TV-1106, a long-acting GH treatment for GH deficiency 2015 ·European Journal of Endocrinology ·Orit Cohen‐Barak, (unknown), Michèle Rasamoelisolo, Merav Bassan, (unknown), Boaz Mendzelevski, Ofer Spiegelstein	15
9	Safety, pharmacokinetics, and pharmacodynamics of TV‐1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects 2014 ·The Journal of Clinical Pharmacology ·Orit Cohen‐Barak, (unknown), (unknown), (unknown), (unknown), Aviva Gross, (unknown), Merav Bassan, Yossi Gilgun‐Sherki, Boaz Mendzelevski, Ofer Spiegelstein	48
10	Effects of a Novel Anticoagulant Compound (TV7130) in an Ovine Model of Septic Shock 2010 ·Shock ·Fuhong Su, (unknown), Xinrong He, (unknown), Jingwei Xie, (unknown), Orit Cohen‐Barak, Michaël Piagnerelli, Jean‐Louis Vincent	3
11	Predicting Phenotype from Genotype: Normal Pigmentation* 2010 ·Journal of Forensic Sciences ·Robert K. Valenzuela, (unknown), (unknown), Nanibaa’ A. Garrison, (unknown), Orit Cohen‐Barak, Drew T. Erickson, F. John Meaney, James Bruce Walsh, Keith C. Cheng, Shosuke Ito, Kazumasa Wakamatsu, Tony Frudakis, Matthew J. Thomas, Murray H. Brilliant	86
12	Stem cell transplantation demonstrates that Sox6 represses εy globin expression in definitive erythropoiesis of adult mice 2007 ·Experimental Hematology ·Orit Cohen‐Barak, Drew T. Erickson, Michael Badowski, Deborah Fuchs, (unknown), David T. Harris, Murray H. Brilliant	16
13	Sox6 Directly Silences Epsilon Globin Expression in Definitive Erythropoiesis 2006 ·PLoS Genetics ·(unknown), Orit Cohen‐Barak, Nobuko Hagiwara, Paul D. Kingsley, Deborah Fuchs, Drew T. Erickson, Elliot Epner, James Palis, Murray H. Brilliant	95
14	Sox6 Directly Silences Epsilon Globin Expression in Definitive Erythropoiesis 2005 ·PLoS Genetics ·(unknown), Orit Cohen‐Barak, Nobuko Hagiwara, Paul D. Kingsley, Deborah Fuchs, Drew T. Erickson, Elliot Epner, James Palis, Murray H. Brilliant	3
15	A 122.5-Kilobase Deletion of the P Gene Underlies the High Prevalence of Oculocutaneous Albinism Type 2 in the Navajo Population 2003 ·The American Journal of Human Genetics ·(unknown), Nanibaa’ A. Garrison, Orit Cohen‐Barak, Tatiana M. Karafet, Richard A. King, Robert P. Erickson, Michael F. Hammer, Murray H. Brilliant	35
16	Sox6 regulation of cardiac myocyte development 2003 ·Nucleic Acids Research ·Orit Cohen‐Barak	49
17	Mutations in the Human Orthologue of the Mouse underwhite Gene (uw) Underlie a New Form of Oculocutaneous Albinism, OCA4 2001 ·The American Journal of Human Genetics ·J.M. Newton, Orit Cohen‐Barak, Nobuko Hagiwara, John M. Gardner, Muriel T. Davisson, Richard A. King, Murray H. Brilliant	254
18	Cloning, characterization and chromosome mapping of the human SOX6 gene 2001 ·Gene ·Orit Cohen‐Barak, Nobuko Hagiwara, Martin F. Arlt, (unknown), Murray H. Brilliant	41
19	Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells. 2001 ·PubMed ·Inbal Braunstein, Orit Cohen‐Barak, Catherine M. Shachaf, (unknown), (unknown), Gordon B. Mills, Maty Tzukerman, Karl Skorecki	34
20	Identification of a Novel Transcription Factor Binding Element Involved in the Regulation by Differentiation of the Human Telomerase (hTERT) Promoter 2000 ·Molecular Biology of the Cell ·Maty Tzukerman, Catherine M. Shachaf, (unknown), Ilana Braunstein, Orit Cohen‐Barak, (unknown), Karl Skorecki	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact